With an industry first 10:1 ratio of CBD to minor cannabinoids, Medterra's new Ultra Broad Spectrum™ is the most efficacious way to experience to the benefits of CBD.
In addition to CBD, Medterra’s Medical Advisors identified four additional key cannabinoids, plus naturally-occurring terpenes and flavonoids for their standout beneficial effects, and then formulated the most efficacious 10:1 ratio of this family of natural compounds — an industry first. The result is our Ultra Broad Spectrum™ Liquid Capsules, a powerful, long-lasting expression of our standard-setting true Ultra Broad Spectrum™ products.